Pre-medication and renal pre-conditioning: A role for alprazolam, atropine, morphine and promethazine

Fundamental and Clinical Pharmacology

Volumn 24, Issue 2, 2010, Pages 189-198

  Pazoki Toroudi, Hamid Reza ^a,b   Ajami, Marjan ^a   Habibey, Rouhollah ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Nano Vichar Pharmaceutical Ltd   (Iran)

Author keywords

Anesthetics; Ischemia reperfusion; Ischemic pre conditioning; Pre medication

Indexed keywords

ALPRAZOLAM; ATROPINE; MORPHINE; PROMETHAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; FEMALE; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ADJUVANTS, ANESTHESIA; ALPRAZOLAM; ANALGESICS, OPIOID; ANIMALS; ANTI-ANXIETY AGENTS; ATROPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE H1 ANTAGONISTS; ISCHEMIC PRECONDITIONING; KIDNEY; MORPHINE; PREMEDICATION; PROMETHAZINE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 77949896708     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00743.x     Document Type: Article

References (52)

1. Abela C.B., Homer-Vanniasinkham S. Clinical implications of ischaemia-reperfusion injury. Pathophysiology (2003) 9 229 240.
2. Aronson S., Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J. Cardiothorac. Vasc. Anesth. (1998) 12 567 586.
3. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 74 1124 1136.
4. Bonventre J.V. Kidney ischemic preconditioning. Curr. Opin. Nephrol. Hypertens. (2002) 11 43 48.
5. Frank R.S., Frank T.S., Zelenock G.B., D'Alecy L.G. Ischemia with intermittent reperfusion reduces functional and morphologic damage following renal ischemia in the rat. Ann. Vasc. Surg. (1993) 7 150 155.
6. Cope D.K., Impastato W.K., Cohen M.V., Downey J.M. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology (1997) 86 699 709.
7. Novalija E., Fujita S., Kampine J.P., Stowe D.F. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology (1999) 91 701 712.
8. Schultz J.E., Rose E., Yao Z., Gross G.J. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. (1995) 268 H2157 H2161.
9. Okubo S., Tanabe Y., Takeda K et al. Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits. Role of delta-opioid receptor. Am. J. Physiol. Heart Circ. Physiol. (2004) 287 H1786 H1791.
10. Marinovic J., Ljubkovic M., Bienengraeber M.W., Bosnjak Z.J. Volatile anesthetic-induced cardiac preconditioning. J. Anesth. (2007) 21 212 219.
11. Tanaka K., Ludwig L.M., Krolikowski J.G. et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury. Role of cyclooxygenase-2. Anesthesiology (2004) 100 525 531.
12. Hu G., Salem M.R., Crystal G.J. Isoflurane and sevoflurane precondition against neutrophil-induced contractile dysfunction in isolated rat hearts. Anesthesiology (2004) 100 489 497.
13. Lee H.T., Ota-Setlik A., Fu Y., Nasr S.H., Emala C.W. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology (2004) 101 1313 1324.
14. Obal D., Rascher K., Favoccia C., Dettwiler S., Schlack W. Post-conditioning by a short administration of desflurane reduced renal reperfusion injury after differing of ischaemia times in rats. Br. J. Anaesth. (2006) 97 783 791.
15. Lee H.T., Kim M., Jan M., Emala C.W. Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am. J. Physiol. Renal Physiol. (2006) 291 F67 F78.
16. Dembo J.B. The use of intravenous anesthesia and sedation techniques in oral and maxillofacial surgery. J. Oral Maxillofac. Surg. (1993) 51 346 351.
17. Raja S.N., Lowenstein E. The birth of opioid anesthesia. Anesthesiology (2004) 100 1013 1015.
18. Brill S., Gurman G.M., Fisher A. A history of neuraxial administration of local analgesics and opioids. Eur. J. Anaesthesiol. (2003) 20 682 689.
19. Lytle J.J. Fifty years of general anesthesia in California oral and maxillofacial surgery. J. Calif. Dent Assoc. (2004) 32 827 830.
20. Kazemisaeid A., Zeinali A.H., Davoodi G. et al. Premedication for coronary angiography: effects on anxiety and hemodynamic status. Indian Heart J. (2007) 59 454 458.
21. Ng E.H., Miao B., Ho P.C. Anxiolytic premedication reduces preoperative anxiety and pain during oocyte retrieval. A randomized double-blinded placebo-controlled trial. Hum. Reprod. (2002) 17 1233 1238.
22. Rodolà F., Cannelli G., Barbi S., Forte E., Anastasio C., Vagnoni S. Cost effective prophylaxys of postoperative nausea and vomiting by anesthetic premedication. Riv. Eur. Sci. Med. Farmacol. (1995) 17 243 246.
23. Hamilton G.R., Baskett T.F. In the arms of Morpheus the development of morphine for postoperative pain relief. Can. J. Anaesth. (2000) 47 367 374.
24. Jablonski P., Howden B.O., Rae D.A., Birrell C.S., Marshall V.C., Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation (1983) 35 198 204.
25. Zhang Y., Wu Y.X., Hao Y.B., Dun Y., Yang S.P. Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. Life Sci. (2001) 68 1013 1109.
26. Yamanouchi K., Yanaga K., Okudaira S., Eguchi S., Furui J., Kanematsu T. [D-Ala2, D-Leu5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat. J. Surg. Res. (2003) 114 72 77.
27. Addison P.D., Neligan P.C., Ashrafpour H. et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am. J. Physiol. (2003) 285 H1435 H1443.
28. Zhao P., Huang Y., Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J. Neuropathol. Exp. Neurol. (2006) 65 945 952.
29. Habibey R., Pazoki-Toroudi H. Morphine dependence protects rat kidney against ischaemia-reperfusion injury. Clin. Exp. Pharmacol. Physiol. (2008) 35 1209 1214.
30. Peart J.N., Gross G.J. Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation (2004) 109 1219 1222.
31. Peart J.N., Gross G.J. Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp. Gerontol. (2004) 39 1021 1026.
32. Lee H.T., Emala C.W. Protein kinase C and G(i/o) proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J. Am. Soc. Nephrol. (2001) 12 233 240.
33. Kingma M.L., Kingma J.G. Effect of alprazolam on ischemia and reperfusion-induced ventricular arrhythmias in the isolated perfused rat heart. Pharmacology (1989) 39 129 136.
34. Schwartz-Bloom R.D., McDonough K.J., Chase P.J., Chadwick L.E., Inglefield J.R., Levin E.D. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil. J. Cereb. Blood Flow Metab. (1998) 18 548 558.
35. Hall E.D., Andrus P.K., Fleck T.J., Oostveen J.A., Carter D.B., Jacobsen E.J. Neuroprotective properties of the benzodiazepine receptor, partial agonist PNU-101017 in the gerbil forebrain ischemia model. J. Cereb. Blood Flow Metab. (1997) 17 875 883.
36. López-Farré A., Bernabeu F., Gómez-Garre D., Ramon y Cajal S., Braquet P., López-Novoa J.M. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. J. Pharmacol. Exp. Ther. (1990) 253 328 333.
37. Oldenburg O., Qin Q., Sharma A.R., Cohen M.V., Downey J.M., Benoit J.N. Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc. Res. (2002) 55 544 552.
38. Oldenburg O., Critz S.D., Cohen M.V., Downey J.M. Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on phosphatidylinositol 3- and Src-kinase activation and mitochondrial K(ATP) channel opening. J. Mol. Cell. Cardiol. (2003) 35 653 660.
39. Fu W., Jiao X. The effect of mannitol and anisodamin on the prevention of free radical injury to post-ischaemia flaps: an experimental study. Br. J. Plast. Surg. (1995) 48 218 221.
40. Yao X.J., Tan Y.H., Xu Z.C., Li X.Y., Chen S.Y. Effects of anisodamine against myocardial ischemia-reperfused injuries and antilipid peroxidation. Zhongguo Yao Li Xue Bao. (1995) 16 152 155.
41. Peng X.Q., Ke J. Effects of 3 henbane drugs on acute forebrain ischemia and reperfusion injury in rats. Zhongguo Yao Li Xue Bao. (1992) 13 357 358.
42. Naarala J., Tervo P., Loikkanen J., Savolainen K. Cholinergic-induced production of reactive oxygen species in human neuroblastoma cells. Life Sci. (1997) 60 1905 1914.
43. Li L., Shou Y., Borowitz J.L., Isom G.E. Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. Toxicol. Appl. Pharmacol. (2001) 177 17 25.
44. Suzuki K., Araki H., Komoike Y., Takeuchi K. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats. Med. Sci. Monit. (2000) 6 908 914.
45. Karádi O., Abdel-Salam O.M., Bódis B., Mózsik G. Preventive effect of atropine on indomethacin-induced gastrointestinal mucosal and vascular damage in rats. Pharmacology (1996) 52 46 55.
46. Tsunada S., Fujimoto K., Gotoh Y. et al. Role of histamine receptors in intestinal repair after ischemia-reperfusion in rats. Gastroenterology (1994) 107 1297 1304.
47. Vannay A., Fekete A., Müller V. et al. Effects of histamine and the h2 receptor antagonist ranitidine on ischemia-induced acute renal failure: involvement of IL-6 and vascular endothelial growth factor. Kidney Blood Press Res. (2004) 27 105 113.
48. Dzierzkowska J., Witanowska A., Wojtecka-Lukasik E. et al. Are histamine H1 receptors involved in ischaemia/reperfusion injury in rat heart? J. Physiol. Pharmacol. (1994) 45 493 499.
49. Hiraga N., Adachi N., Liu K., Nagaro T., Arai T. Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur. J. Pharmacol. (2007) 557 236 244.
50. Adachi N., Liu K., Arai T. Alleviation of ischemic neuronal damage by postischemic loading with histidine in the rat striatum. Brain Res. (2004) 998 136 138.
51. Adachi N., Liu K., Motoki A., Nishibori M., Arai T. Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats. Eur. J. Pharmacol. (2006) 544 181 187.
52. Rochette L., Yao-Kouame J., Bralet J., Opie L.H. Effects of promethazine on ischemic and reperfusion arrhythmias in rat heart. Fundam. Clin. Pharmacol. (1988) 2 385 397.